← All trials
NCT05573802
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 24, 2022
- Primary completion
- Oct 31, 2026
- Completion date
- Oct 31, 2026
- First posted
- Oct 10, 2022
- Last posted
- Oct 13, 2022
- Enrollment
- 36
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Hellenic Society of HematologyLead sponsor
- GlaxoSmithKlineCollaborator
- National Kapodistrian University of AthensOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.